T3 Companies »

Vyne Therapeutics shares owned by T3 Companies

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by T3 Companies from 13F filings

Historical chart of T3 Companies investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by T3 Companies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by T3 Companies

Quarter filed Position value Share count Share price at filing
2026-03-31 $565k 945k 0.60

More positions owned by T3 Companies

Micron Technology (MU)
Hologic
Liquidia Corporation Com New (LQDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
United Sts Oil Units Call Option (USO)
Futurecrest Acquisition Corp Cl A Ord Shs (FCRS)
Warner Bros Discovery Com Ser A (WBD)
Electronic Arts (EA)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Abivax Sa Sponsored Ads (ABVX)
Clearwater Analytics Hldgs I Cl A (CWAN)
Nike CL B (NKE)
Microsoft Corporation (MSFT)
Ishares Tr Msci India Etf (INDA)
Ishares Silver Tr Ishares (SLV)

View all positions for T3 Companies

Top funds holding Vyne Therapeutics

Nantahala Capital Management
Lynx1 Capital Management
Shay Capital
Frigate Ventures
ADAR1 Capital Management
T3 Companies
Braidwell
Citadel Advisors
KVP Capital Advisors
Two Sigma Investments
Acadian Asset Management
Geode Capital Management
Vanguard Group
Ikarian Capital
Vanguard Capital Management

View all funds holding Vyne Therapeutics